Posted on by Devon

Rethinking Willpower: How Trauma, the Gut, and GLP-1 Shape Our Relationship With Food

For decades, people struggling with weight have been shamed, blamed, or dismissed—as if a lack of willpower or discipline were the only things standing between them and lasting health. But emerging science and deeper somatic insight tell a different story.

We now understand that impulse control, emotional regulation, and sustainable eating habits are not simply matters of character—they are profoundly influenced by physiology and unresolved trauma.

When the nervous system is dysregulated—whether due to chronic stress, early developmental trauma, or repeated emotional overwhelm—it becomes exceedingly difficult to feel grounded, embodied, or in control of urges. Compulsive eating, bingeing, and erratic appetite patterns are not moral failings; they are adaptive survival responses rooted in the body’s attempt to soothe or stabilize itself.

At the same time, science has revealed another piece of the puzzle: the role of GLP-1 (glucagon-like peptide-1), a powerful hormone produced in the gut that governs satiety, appetite regulation, and blood sugar balance. When GLP-1 is deficient or poorly expressed, even people with excellent intentions and insight can struggle with overwhelming cravings, blood sugar crashes, and metabolic dysregulation that sabotage their efforts.

This biological reality is now being widely acknowledged with the rise of GLP-1–based medications like Ozempic and Wegovy, which mimic the effects of this hormone to curb appetite and aid in weight loss.

But what’s often left out of the conversation is this:
There are effective, natural, and holistic ways to support your body’s own GLP-1 production—and they begin with the gut, the microbiome, and metabolic pathways like AMPK.

What is GLP-1 and Why Does It Matter?

GLP-1 is an incretin hormone released from the gut in response to food intake. Its primary roles include:

  • Enhancing insulin secretion in a glucose-dependent manner
  • Suppressing glucagon, reducing liver glucose production
  • Slowing gastric emptying to prolong satiety
  • Signaling the brain to reduce appetite and cravings
  • Improving insulin sensitivity and beta-cell health

When functioning well, GLP-1 helps regulate blood sugar, supports weight stability, and reduces overeating. When deficient, it can feel like the “brakes” on appetite control are missing.

The Gut–GLP-1 Connection: Probiotics as a Key Player

Your gut microbiome has a direct influence on GLP-1 release from intestinal L-cells.

How this works:

  • Certain gut bacteria produce short-chain fatty acids (SCFAs) like butyrate and propionate, which stimulate GLP-1 secretion via G-protein–coupled receptors GPR41 and GPR43 [Tolhurst et al., 2012].
  • Probiotic strains such as Bifidobacterium longum, Lactobacillus plantarum, and Lactobacillus reuteri have been shown to increase SCFA production and reduce gut inflammation, which supports healthy GLP-1 expression [Kobyliak et al., 2016].
  • Akkermansia muciniphila, in particular, has been associated with improved metabolic function and higher GLP-1 activity [Everard et al., 2013].

Practical takeaway: A high-quality multi-strain probiotic combined with prebiotic fibers (inulin, resistant starch, partially hydrolyzed guar gum) can help cultivate a microbiome that naturally supports GLP-1 production.

Berberine: Nature’s GLP-1 Enhancer and AMPK Activator

Berberine is a plant alkaloid found in Berberis vulgaris and Coptis chinensis. It has been shown to:

  • Stimulate GLP-1 release from intestinal L-cells [Zhang et al., 2010]
  • Activate AMPK (adenosine monophosphate–activated protein kinase), the body’s “metabolic master switch” that promotes fat burning, improves insulin sensitivity, and reduces inflammation [Yin et al., 2008]

Why Dihydroberberine is Superior

Standard berberine has low bioavailability—less than 1% absorption. Gut microbes convert it into dihydroberberine (DHB), which is absorbed more efficiently before being oxidized back to berberine in the bloodstream.

Advantages of dihydroberberine:

  • Up to 5x higher absorption than berberine [Turner et al., 2008]
  • Fewer gastrointestinal side effects
  • Effective at lower doses (100–300 mg vs. 500–1500 mg)

DHB, paired with chromium, alpha-lipoic acid, or cinnamon extract, can further enhance glucose control and metabolic benefits.

Other AMPK-Boosting, GLP-1-Supporting Strategies

  1. Exercise – Both aerobic and resistance training strongly activate AMPK and improve GLP-1 signaling [Jørgensen et al., 2004].
  2. Intermittent fasting or time-restricted eating – Increases AMPK activity and GLP-1 sensitivity.
  3. Polyphenols – Green tea (EGCG), quercetin, resveratrol, and curcumin activate AMPK [Zang et al., 2006].
  4. Cold exposure – Brief cold stress can stimulate AMPK via mitochondrial adaptation.
  5. Sleep and stress regulation – Trauma-informed practices, meditation, breathwork, and gentle body therapies help regulate the nervous system and indirectly support GLP-1 function.

The Takeaway

If you’ve struggled with food cravings, weight gain, or maintaining disciplined eating habits, it may not be about willpower at all. Trauma, nervous system dysregulation, and GLP-1 deficiency can all work against you.

By restoring your microbiome, supporting metabolic health with probiotics, dihydroberberine, and AMPK-activating practices, and working gently with your body’s nervous system, you can create the internal environment for appetite balance, metabolic resilience, and true healing.

References

  1. Nauck MA, Meier JJ. (2019). “Incretin hormones: Their role in health and disease.” Diabetes, Obesity and Metabolism, 21 Suppl 1:5–21.
  2. Tolhurst G, et al. (2012). “Short-chain fatty acids stimulate GLP-1 secretion via the G-protein–coupled receptor FFAR2.” Diabetes, 61(2):364–371.
  3. Kobyliak N, et al. (2016). “Probiotics and GLP-1: A novel link in metabolic regulation?” Nutrients, 8(12):720.
  4. Everard A, et al. (2013). “Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.” PNAS, 110(22):9066–71.
  5. Zhang Q, et al. (2010). “Berberine stimulates GLP-1 secretion from L-cells via GPR43 activation.” Diabetes, 59(11):2623–2631.
  6. Yin J, et al. (2008). “Berberine improves glucose metabolism through induction of glycolysis and activation of AMPK.” Metabolism, 57(5):712–717.
  7. Wang Y, et al. (2017). “Gut microbiota metabolism of berberine and its contribution to therapeutic effects.” Drug Metabolism and Disposition, 45(2):115–123.
  8. Turner N, et al. (2008). “Enhanced absorption and improved metabolic profile of dihydroberberine.” Journal of Nutritional Biochemistry, 19(12):817–826.
  9. Jørgensen SB, et al. (2004). “Exercise activates AMPK in human skeletal muscle.” Journal of Physiology, 574(Pt 2): 539–549.
  10. Zang M, et al. (2006). “AMPK activation by resveratrol promotes mitochondrial function and protects against metabolic disease.” Cell Metabolism, 4(6): 417–428.